Week in Preview - WOW restructure & upcoming RMD results
Resmed acquires CareTouch
Resmed: Losing heart
Montgomery Investment Management
We wrote about ResMed (RMD) a few months ago in Livewire, warning of the downside
From @morgans following the Resmed (RMD) result on Friday: Resmed (RMD, Hold, Price Target A$5.40) - 2QFY14 earnings were below expectations as volumes and...